BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25724415)

  • 41. Reported breast symptoms in the National Breast and Cervical Cancer Early Detection Program.
    Ryerson AB; Miller J; Eheman CR
    Cancer Causes Control; 2015 May; 26(5):733-40. PubMed ID: 25754109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Uptake of breast and cervical cancer screening in four Gulf Cooperation Council countries.
    So VHT; Channon AA; Ali MM; Merdad L; Al Sabahi S; Al Suwaidi H; Al Ajeel A; Osman N; Khoja TAM
    Eur J Cancer Prev; 2019 Sep; 28(5):451-456. PubMed ID: 30260812
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Public education and targeted outreach to underserved women through the National Breast and Cervical Cancer Early Detection Program.
    Levano W; Miller JW; Leonard B; Bellick L; Crane BE; Kennedy SK; Haslage NM; Hammond W; Tharpe FS
    Cancer; 2014 Aug; 120 Suppl 16(0 16):2591-6. PubMed ID: 25099902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost of services provided by the National Breast and Cervical Cancer Early Detection Program.
    Ekwueme DU; Subramanian S; Trogdon JG; Miller JW; Royalty JE; Li C; Guy GP; Crouse W; Thompson H; Gardner JG
    Cancer; 2014 Aug; 120 Suppl 16(Suppl 16):2604-11. PubMed ID: 25099904
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Time from breast cancer diagnosis to treatment among Idaho's National Breast and Cervical Cancer Early Detection Program population, 2011-2017.
    Johnson CJ; Morawski BM; Hobbs L; Lewis D; Cariou C; Rycroft RK
    Cancer Causes Control; 2021 Jun; 32(6):667-673. PubMed ID: 33665701
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Implementation of the National Breast and Cervical Cancer Early Detection Program: the beginning.
    Lee NC; Wong FL; Jamison PM; Jones SF; Galaska L; Brady KT; Wethers B; Stokes-Townsend GA
    Cancer; 2014 Aug; 120 Suppl 16(0 16):2540-8. PubMed ID: 25099896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors associated with accurate cancer detection during a clinical breast examination.
    Bobo J; Lee N
    Ann Epidemiol; 2000 Oct; 10(7):463. PubMed ID: 11018380
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Health Reform, Medicaid Expansions, and Women's Cancer Screening.
    Ku L; Bysshe T; Steinmetz E; Bruen BK
    Womens Health Issues; 2016; 26(3):256-61. PubMed ID: 26926159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preventive care: female cancer screening, 1996-2000.
    Adams EK; Florence CS; Thorpe KE; Becker ER; Joski PJ
    Am J Prev Med; 2003 Nov; 25(4):301-7. PubMed ID: 14580631
    [TBL] [Abstract][Full Text] [Related]  

  • 50. About invasive cervical cancer: a French population based study between 1998 and 2010.
    Lorin L; Bertaut A; Hudry D; Beltjens F; Roignot P; Bone-Lepinoy MC; Douvier S; Arveux P
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():1-6. PubMed ID: 26004674
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are uninsured women in a national screening program having longer intervals between cervical cancer screening tests?
    Bartley SJ; Benard V; Tai E; Rockwell T; Kenney K; Richardson LC
    Prev Med; 2020 Jun; 135():106078. PubMed ID: 32247009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Results from the National Breast and Cervical Cancer Early Detection Program, October 31, 1991-September 30, 1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Jul; 43(29):530-4. PubMed ID: 8028574
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Explaining variation across grantees in breast and cervical cancer screening proportions in the NBCCEDP.
    Subramanian S; Tangka FK; Ekwueme DU; Trogdon J; Crouse W; Royalty J
    Cancer Causes Control; 2015 May; 26(5):689-95. PubMed ID: 25840557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
    May DS; Lee NC; Nadel MR; Henson RM; Miller DS
    AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
    [TBL] [Abstract][Full Text] [Related]  

  • 55. National health system characteristics, breast cancer stage at diagnosis, and breast cancer mortality: a population-based analysis.
    Duggan C; Trapani D; Ilbawi AM; Fidarova E; Laversanne M; Curigliano G; Bray F; Anderson BO
    Lancet Oncol; 2021 Nov; 22(11):1632-1642. PubMed ID: 34653370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Update: National Breast and Cervical Cancer Early Detection Program--July 1991-September 1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Jun; 45(23):484-7. PubMed ID: 8628207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of Medicaid expansion on women with gynecologic cancer: a difference-in-difference analysis.
    Albright BB; Nasioudis D; Craig S; Moss HA; Latif NA; Ko EM; Haggerty AF
    Am J Obstet Gynecol; 2021 Feb; 224(2):195.e1-195.e17. PubMed ID: 32777264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors associated with adequacy of diagnostic workup after abnormal breast cancer screening results.
    Schootman M; Myers-Geadelmann J; Fuortes L
    J Am Board Fam Pract; 2000; 13(2):94-100. PubMed ID: 10764189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Update: National Breast and Cervical Cancer Early Detection Program, July 1991-July 1992.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Oct; 41(40):739-43. PubMed ID: 1328839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of screening mammography in the United States and the United kingdom.
    Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K
    JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.